Full Press Release Details
zynex8kex991_6282005.txt
APPROVED BY THOMAS SANDGAARD FOR DISTRIBUTION ON 6/28/05___________(signed)
President and Chief Executive Officer
The Wall Street Group, Inc.
FOR IMMEDIATE RELEASE:
ZYNEX CEO THOMAS SANDGAARD'S INTERVIEW WITH THE WALL STREET
TRANSCRIPT AVAILABLE ON COMPANY'S WEB SITE
LITTLETON, Colo., June 28, 2005 - Zynex Medical Holdings, Inc. (OTCBB: ZYNX), a
provider of pain management systems and electrotherapy products for medical
patients with functional disability, today announced The Wall Street Transcript
has published an in-depth interview with President and Chief Executive Officer
The interview is available free on Zynex' web site (www.zynexmed.com) or to
subscribers at The Wall Street Transcript's web site (www.twst.com).
"We developed the Neuromove(TM), a totally new and innovative and highly
effective device to help stroke survivors and those suffering spinal cord
injuries to regain movement for the impaired regions of their bodies," Mr.
Sandgaard stated during the interview. Discussing the Company's outlook, he said
that Zynex will continue to develop its sales and marketing capabilities and "we
have very high expectations as to a significant growth over the next few years."
Zynex Medical Holdings, Inc., (www.zynexmed.com), a leading provider of
therapeutic devices for patients with functional disability through the
creation, distribution, and marketing of electrotherapy devices since 1996,
strives to uphold its mission to improve the quality of life of patients
suffering from debilitating pain or illness by providing innovative technology.
Utilizing a unique combination of electromyographic (EMG) technology combined
with a system of instruction and reinforcement, including electrical muscle
stimulation (EMS), Zynex offers new treatment options to post-stroke and spinal
Safe Harbor Provision
Certain statements in this release are "forward-looking" and as such are subject
to numerous risks and uncertainties. Actual results may vary significantly from
the results expressed or implied in such statements. Factors that could cause
actual results to materially differ from forward-looking statements include, but
are not limited to, the Company's ability to meet terms and conditions required
to obtain project financing, risks and delays associated with product
development, risk of market acceptance of new products, technology or product
obsolescence, competitive risks, reliance on development partners and additional